European Journal of Pediatrics

, Volume 176, Issue 5, pp 581–589 | Cite as

Effectiveness of prothrombin complex concentrate (PCC) in neonates and infants with bleeding or risk of bleeding: a systematic review and meta-analysis

Original Article

Abstract

To systematically evaluate the effectiveness of prothrombin complex concentrate (PCC) in neonates and infants, we performed a systematic review and meta-analysis based on current evidence. Quality of studies was assessed by Cochrane Collaboration’s risk of bias tool and Newcastle-Ottawa quality assessment scale. For dichotomous data, we obtained the number of events and total number and calculated the relative risk (RR) with 95% confidence intervals (CI). For continuous variables, we obtained mean and standard deviation (SD) values and calculated mean difference (MD) with 95% CI. We identified six trials and two cohort studies. For trials, selection bias and performance bias were high, while detection bias, attrition bias, and reporting bias were relatively low. For cohort studies, selection bias was low. Both individual studies and meta-analysis failed to find any benefit of PCC on mortality. Meta-analysis also failed to show any benefit in reducing intracranial hemorrhage. The effectiveness of PCC on the correction of hemostatic defects was inconsistent among studies. In addition, PCC was not more effective than fresh frozen plasma (FFP) in correcting hemostatic defects.

Conclusion: There is insufficient evidence to allow a recommendation for use of PCC in neonates and infants.

What is Known:

• Prothrombin Complex Concentrate is becoming increasingly used off-label for treatment of neonates and infants with severe bleeding or risk of severe bleeding.

• Some case reports showed PCC seemed to be effective for infants and children with coagulation factor deficiency, but evidence about the effectiveness of PCC to reverse serious Vitamin K Deficiency Bleeding is limited.

What is New:

• As far as we know, this is the first systematic review that evaluates the effectiveness of PPC in neonates with bleeding or risk of bleeding.

• There is insufficient evidence to allow a recommendation for use of PCCs in neonates and infants.

Keywords

Prothrombin complex concentrate Neonates Infants Systematic review Meta-analysis 

Abbreviations

APTT

Activated partial thromboplastin time

CBM

Chinese Biomedical Literature Database

CDDB

China Dissertation Database

CDMB

China Doctoral Dissertations and Master’s Theses Full-text Databases

CI

Confidence intervals

CNKI

China National Knowledge Infrastructure

FDA

Food and Drug Administration

FFP

Fresh frozen plasma

HIE

Hypoxic ischemic encephalopathy

ICH

Intracranial hemorrhage

ICTRP

International Clinical Trials Registry Platform

MD

Mean difference

PCC

Prothrombin complex concentrate

PQDD

ProQuest Digital Dissertation

PT

Prothrombin time

RR

Relative risk

SD

Standard deviation

TG

Thrombin generation

WHO

World Health Organization

Notes

Acknowledgement

We thank Program for Yangtze River Scholars and Innovative Research Team in University (No. IRT0935) and the Group of People with Highest Risk of Drug Exposure of International Network for the Rational Use of Drugs, China, for its support.

Authorsʼ contributions

Linan Zeng searched and selected the literatures, assessed the quality of studies, and wrote the paper. Imti Choonara analyzed the data and wrote the paper. Lingli Zhang extracted the data and revised the paper. Youping Li wrote and revised the paper. Jing Shi selected the literature and analyzed the data.

Compliance with ethical standards

Funding

This study was funded by the Natural Science Foundation of China (No. 81373381) and the National Science Foundation for Young Scholars of China (No. 71503177).

Conflict of interest

The authors declare that they have no conflict of interest.

Research involving human participants and/or animals

This article does not contain any studies with human participants performed by any of the authors.

Ethical approval

For this type of study, formal consent is not required.

References

  1. 1.
    Andrew M, Paes B, Milner R (1987) Development of the coagulation system inthe full-term infant. Blood 70:165–172PubMedGoogle Scholar
  2. 2.
    Andrew M, Paes B, Milner R (1988) Development of the human coagulation. System in the healthy premature infant. Blood 80:1998–2005Google Scholar
  3. 3.
    Bowles L, Baker K, Khair K, Mathias M, Liesner R (2009) Prophylaxis withprothrombin complex concentrate in 4 children with severe congenital factor xdeficiency. Haemophilia 15:401–403CrossRefPubMedGoogle Scholar
  4. 4.
    Cochrane and book for Systematic Reviews of Interventions. Version 5.1.0.updated 2011. Editors: Julian PT Higgins and Sally Green. Available from: http://handbook.cochrane.org/
  5. 5.
    Cornelissen M, von KR, Loughnan P, Schubiger G (1997) Prevention of vitamin K deficiency bleeding: efficacy of different multiple oral dose schedules of vitamin K. Eur J Pediatr 156:126–130CrossRefPubMedGoogle Scholar
  6. 6.
    Cvirn G, Gallistl S, Leschnik B, Muntean W (2003) Low tissue factor pathway inhibitor (TFPI) together with low antithrombin allows sufficient thrombin generation in neonates. ThrombHaemost 1:263–268CrossRefGoogle Scholar
  7. 7.
    Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research (2012) FDA pharmacovigilance plan review: prothrombin complex concentrateGoogle Scholar
  8. 8.
    Franchini M, Lippi G (2010) Prothrombin complex concentrates: an update. Blood Transfus 8:149–154PubMedPubMedCentralGoogle Scholar
  9. 9.
    Gu Q, Ma YJ, Yang CY (2004) The effection of prothrombin complex on the coagulation of neonatal hypoxic-ischemic encephalopathy. J Appl Clin Pedia-tri 19:464–465Google Scholar
  10. 10.
    Guzzetta NA, Szlam F, Kiser AS, Fernandez JD, Szlam AD, Leong T, Tanaka KA (2014) Augmentation of thrombin generation in neonates undergoing cardiopulmonary bypass. Br J Anaesth 112:319–327CrossRefPubMedGoogle Scholar
  11. 11.
    Hanke AA, Joch C, Gorlinger K (2013) Long-term safety and efficacy of a pasteurized nanofiltrated prothrombin complex concentrate (Beriplex P/N): a pharmacovigilance study. Br J Anaesth.:1–9Google Scholar
  12. 12.
    Higgins JPT, Altman DG, Sterne JAC (2011) Assessing risk of bias in included studies. In: Higgins JPT, Green S (eds) Cochrane handbook for systematic reviews of interventions. Version 5.1.0.Cochrane CollaborationGoogle Scholar
  13. 13.
    Huang CH, Zeng L (2013) The effection of prothrombin complex on intracranial hemorrhage caused by late onset vitamin K deficiency bleeding. Contemporary Medicine 19:57Google Scholar
  14. 14.
    Kenet G, AKC C, Soucie JM, Kulkarni R (2010) Bleeding disorders in neonates. Haemophilia 16:168–174CrossRefPubMedGoogle Scholar
  15. 15.
    Kuperman AA, Brenner B, Kenet G Intraventricular haemorrhage in preterm infants—can we improve outcome by addressing coagulation? J Matern Fetal Neonatal Med. Early Online:1–3Google Scholar
  16. 16.
    Kupermanab AA, Brennercd B, Kenetef G (2015) Intraventricularhaemorrhage in preterm infants—can we improveoutcome by addressing coagulation? J Matern Fetal Neonatal Med Suppl 1:2265–2267CrossRefGoogle Scholar
  17. 17.
    Li W, Chen J (2004) Efficacy of prothrombin complex on premature children of gastrointestinal hemorrhage. Sichuan Medical Journal 25:1131–1132Google Scholar
  18. 18.
    Lin GX, Luo YM, Chen L (2010) 32 cases of intracranial hemorrhage caused by late onset vitamin K deficiency bleeding treated with prothrombin complex. Fujian Med J 32:6–8Google Scholar
  19. 19.
    Motohara K, Endo F, Matsuda I (1987) Screening for late neonatal vitamin K deficiency by acarboxyprothrombin in dried blood spots. Arch Dis Child 62:370–375CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    National advisory committee on blood and blood products (2011) Recommendations for use of prothrombin complex concentrates in CanadaGoogle Scholar
  21. 21.
    Nova Scotia Provincial Blood Coordinating Program (2013) Utilization guidelines for prothrombin complex concentrates in Nova ScotiaGoogle Scholar
  22. 22.
    Rech MA, Wittekindt L, Friedman SD, Kling K, Ubogy D (2015) Prothrombin complex concentrate for intracerebral hemorrhage secondary to vitamin K deficiency bleeding in a 6-week-old child. Pediatr 167:1443–1444CrossRefGoogle Scholar
  23. 23.
    Review Manager(RevMan)[Computer program] 2008. Version 5.0.Copenhagen: The Nordic Cochrane Centre, The Cochrane CollaborationGoogle Scholar
  24. 24.
    Scott LJ (2009) Prothrombin complex concentrate (BeriplexP/N). Drugs 69:1977–1984CrossRefPubMedGoogle Scholar
  25. 25.
    Thomas DB, Burnard ED (1973a) Prevention of intravascular haemorrhage in low- birth weight babies. Lancet 2:562CrossRefPubMedGoogle Scholar
  26. 26.
    Thomas DB, Burnard ED (1973b) Prevention of intraventricular haemorrhage in babies receiving artificial ventilation. Med J Aust 1:933–936PubMedGoogle Scholar
  27. 27.
    Turner T, Prowse CV, Prescott RJ, Cash JD (1981) A clinical trial on the early detection and correction of haemostatic defects in selected high-risk neonates. Br J Haematol 47:65–75CrossRefPubMedGoogle Scholar
  28. 28.
    Von KR, Hanawa Y (1993) Neonatal VK prophylaxis. Report of scientific and standardization subcommittee on perinatal haemostasis. Thromb Haemost 69:293–295Google Scholar
  29. 29.
    Walt H, Kurz R, Mitterstieler G (1973) Intracranial haemorrhage in low-birth-weight infants and prophylactic administration of coagulation-factor concentrate. Lancet 301:1284–1286CrossRefGoogle Scholar
  30. 30.
    Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M,Tugwell P. The Newcastle- Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. www.ohri.ca/programs/clinical_epidemiology/oxford.asp
  31. 31.
    Yang J, Li YX (2011) Prevention and treatment of intraventricular haemorrhage in premature using prothrombin complex combined with phenobarbital. World Health Digest Medical Periodiea 8:57–58Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  1. 1.Department of Pharmacy/Evidence-Based Pharmacy CenterWest China Second University Hospital, Sichuan UniversityChengduChina
  2. 2.Key Laboratory of Birth Defects and Related Diseases of Women and ChildrenSichuan University, Ministry of EducationChengduChina
  3. 3.Academic Division of Child HealthUniversity of Nottingham, Derbyshire Children’s HospitalDerbyUK
  4. 4.Chinese Evidence-Based Medicine Centre/Chinese Cochrane CenterWest China Hospital, Sichuan UniversityChengduChina
  5. 5.Department of NeonatologyWest China Second University Hospital, Sichuan UniversityChengduChina

Personalised recommendations